12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers

  • Unicycive Therapeutics UNCY shares increased by 114.3% to $1.05 during Monday's pre-market session. The company's market cap stands at $15.8 million.
  • BridgeBio Pharma BBIO stock moved upwards by 56.39% to $17.0. The market value of their outstanding shares is at $2.5 billion.
  • vTv Therapeutics VTVT stock increased by 48.51% to $1.2. The company's market cap stands at $97.7 million.
  • Kala Pharmaceuticals KALA shares increased by 27.46% to $21.35. The company's market cap stands at $39.9 million. The company's, Q4 earnings came out yesterday.
  • TCR2 Therapeutics TCRR shares rose 25.61% to $1.52. The market value of their outstanding shares is at $58.7 million.
  • Armata Pharmaceuticals ARMP shares increased by 16.66% to $3.22. The market value of their outstanding shares is at $116.3 million.

Losers

  • Aclaris Therapeutics ACRS shares decreased by 36.5% to $8.11 during Monday's pre-market session. The company's market cap stands at $540.8 million.
  • Esperion Therapeutics ESPR stock decreased by 33.76% to $4.2. The market value of their outstanding shares is at $321.6 million.
  • Adaptimmune Therapeutics ADAP stock decreased by 26.14% to $1.3. The company's market cap stands at $212.9 million. The company's, Q4 earnings came out today.
  • Rubius Therapeutics RUBY shares declined by 19.94% to $0.1. The company's market cap stands at $9.0 million.
  • Sesen Bio SESN shares declined by 13.25% to $0.54. The company's market cap stands at $108.4 million. As per the news, the Q4 earnings report came out 4 days ago.
  • Etao International Co ETAO stock fell 12.84% to $1.97. The company's market cap stands at $208.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!